Phase 3b multicenter, randomized, placebo-controlled, double-blind study evaluating immunogenicity and safety of a 3rd and 4th dose of StaphVAX, a bivalent Staphylococcus aureus glycoconjugate vaccine in adults with end-stage renal disease
Phase of Trial: Phase III
Latest Information Update: 03 Jan 2008
At a glance
- Drugs Staphylococcus aureus vaccine (Primary)
- Indications Staphylococcal infections
- Focus Pharmacodynamics
- Acronyms SHIELD-2
- 03 Jan 2008 Status changed from in progress to discontinued.
- 21 Oct 2005 New trial record.